SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?


To: margie who wrote (5613)11/2/1998 10:19:00 AM
From: scaram(o)uche  Read Replies (1) | Respond to of 6136
 
Kathleen Whatshername just reported on CNBC. Wo! Patients on amprenavir will only need to take two pills/day, a huge advantage over current protocols, where patients take 20-30 pills/day!

(you don't assume that she's listening to the Glaxo line, huh?)

Wo! Gosh! Gee, Whillickers!!



To: margie who wrote (5613)11/2/1998 5:30:00 PM
From: Sidney Reilly  Read Replies (1) | Respond to of 6136
 
margie,
Thanks for the info, much appreciated. Bob